ADDvise Group’s nomination committee for the Annual General Meeting 2022

08-10-2021   Regulatory press release

In accordance with the resolution at the 2021 annual general meeting of ADDvise Group AB, the nomination committee for the annual general meeting 2022 shall be composed of representatives of the three largest shareholders by votes listed in the shareholders’ register, which is maintained by Euroclear Sweden as of 30 June 2021, and the chairman of the board of directors acting as rapporteur. The representative appointed by the largest shareholder by votes shall be appointed chairman of the nomination committee.

The nomination committee has now been appointed and consists of the following members:

  • Per-Anders Tammerlöv (chairman of the nomination committee) appointed by Rikard Akhtarzand, shareholder through direct and indirect ownership
  • Per Åhlgren, shareholder through indirect ownership
  • Magnus Vahlquist, shareholder through direct and indirect ownership
  • Staffan Torstensson, chairman of ADDvise Group AB

The nomination committee shall prepare proposals for the 2022 annual general meeting regarding the appointment of chairman of the meeting, chairman of the board of directors, and other directors of the board and remuneration to the directors of the board and to the auditor.

Shareholders, who wish to present proposals to the nomination committee for the 2022 annual general meeting can submit them by post no later than 31 January 2022 to: ADDvise Group AB, att: Nomination Committee, Grev Turegatan 30, SE-114 38 Stockholm.

The Annual General Meeting 2022 in ADDvise Group AB will be held on the 6 May 2022.

For further information, please contact:

Hanna Myhrman, General Counsel
+46 709 82 92 23

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50,, is the Company's Certified Adviser. Additional information is available at    

Latest press releases

ADDvise increases long-term financial targets


The Board of ADDvise Group AB has decided to update the long-term financial targets for EBITDA margin and revenue growth based on the strong financial performance and the visibility on the upcoming quarters. The EBITDA margin target has been increased from 20% to 28 % and the annual growth target from 25% to 30 %.…

ADDvise announces early redemption of existing bonds 2021/2024


ADDvise Group AB (publ) (the “Company”) announces today that it will redeem in full its outstanding bond loan with ISIN SE0015222088 (the “Bonds” and “Early Redemption”) subject to the successful issuance of new bonds as announced by the Company through a press release on 11 May 2023. Provided that the conditions for Early Redemption are…

ADDvise extends the agreement with Laborie at a value of SEK 48 million


ADDvise Group’s subsidiary Sonesta Medical AB extends the agreement with Laborie Medical Technologies (“Laborie”). The agreement is giving Laborie the right to sell Sonesta Medical’s urology- and gynecology patient positioning equipment and video fluoroscopy tables worldwide, with an exclusive right to distribute in USA and some European countries. Laborie commits to a minimum volume of…